Atlas Trials

Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Clinical trial NCT05365438 · RECRUITING

Trial details

NCT number
NCT05365438
Sponsor
Seoul National University Bundang Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
DyslipidemiasAtherosclerosisDiabetes Mellitus, Type 2
Start date
2022-10-01
Primary completion
2026-12-31
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.